- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced or Metastatic Solid Tumor in United Kingdom
Total 4982 results
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States
-
Eli Lilly and CompanyCompletedAdvanced Solid TumorsUnited States
-
Antisoma ResearchCompleted
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable MelanomaUnited States
-
Calithera Biosciences, IncCompletedAdvanced Solid TumorsUnited States
-
M.D. Anderson Cancer CenterCompletedSolid Tumor | Advanced CancerUnited States
-
Debiopharm International SARecruitingAdvanced Solid TumorsSpain, United States, Switzerland
-
Kyowa Kirin, Inc.AstraZenecaCompletedAdvanced Solid TumorsUnited States
-
Suzhou Transcenta Therapeutics Co., Ltd.Completed
-
Millennium Pharmaceuticals, Inc.Completed
-
R-PharmCompletedNeoplasms | Advanced Solid TumorsUnited States
-
Herbert HurwitzNovartis; Genentech, Inc.CompletedAdvanced Solid TumorsUnited States
-
Mirati Therapeutics Inc.Aadi Bioscience, Inc.Active, not recruitingNSCLC | Metastatic Cancer | Advanced Cancer | Solid Tumor, Adult | Malignant Neoplastic DiseaseUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
PfizerCompletedA First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Korea, Republic of, Italy
-
Incyte CorporationActive, not recruitingAdvanced Solid TumorsUnited States, Sweden, Netherlands, Norway, Denmark
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Cancer or Locally Advanced | Patients Receiving Palliative RadiationUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
Kezar Life Sciences, Inc.Recruiting
-
Eli Lilly and CompanyTerminated
-
AbbVieCompleted
-
AVEO Pharmaceuticals, Inc.Completed
-
CDR-Life AGRecruitingSelect Advanced Solid TumorsUnited States, Denmark
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
BioMed Valley Discoveries, IncCompletedAdvanced Solid TumorsUnited States
-
Bien-Willner Physicians Group PANo One Left Alone; Carolina Blood and Cancer Care AssociatesNot yet recruitingAdvanced Cancer | Myeloid Malignancy | Solid Tumor, AdultUnited States
-
Cancer Research UKTeon Therapeutics, Inc.Recruiting
-
MedImmune LLCCompletedStudy to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Japan
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Deciphera Pharmaceuticals LLCCompletedLocally Advanced or Metastatic Solid TumorUnited States
-
Eli Lilly and CompanyCompletedAdvanced Solid TumorsUnited States
-
AbbVie (prior sponsor, Abbott)Completed
-
BiogenCompleted
-
Merrimack PharmaceuticalsSanofiCompletedAdvanced Solid TumorsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
MedImmune LLCCompleted
-
Eli Lilly and CompanyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Onconova Therapeutics, Inc.CompletedNeoplasms | Cancer | Advanced Cancer | Solid TumorsUnited States
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
Gannex Pharma Co., Ltd.Ascletis Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
PfizerCompletedAdvanced Solid TumorsUnited States
-
Arog Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States, Australia
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedAdvanced Solid TumorsUnited States, Japan
-
M.D. Anderson Cancer CenterNot yet recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Institute of Nursing Research (NINR)Active, not recruitingAdvanced Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Genelux CorporationCompletedAdvanced Cancers (Solid Tumors)United Kingdom
-
Shanghai YingLi Pharmaceutical Co. Ltd.Not yet recruitingAdvanced Solid TumorsUnited States